metastatic renal cell carcinoma
Showing NaN - NaN of 14
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Nephrectomy
- +4 more
-
Birmingham, Alabama
- +414 more
Dec 30, 2022
Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal
Recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Axitinib
- Nivolumab
-
Birmingham, Alabama
- +255 more
Aug 24, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial in United
Recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- +2 more
- Cytoreductive Nephrectomy
- Active Comparator
-
Birmingham, Alabama
- +223 more
Nov 8, 2021
Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (CB-839, Cabozantinib, Placebo)
Completed
- Advanced Renal Cell Carcinoma
- Metastatic Renal Cell Carcinoma
- CB-839
- +2 more
-
Birmingham, Alabama
- +132 more
Aug 18, 2021
Metastatic Renal Cell Carcinoma Trial in Worldwide (Tivozanib, Sunitinib)
Terminated
- Metastatic Renal Cell Carcinoma
-
Los Angeles, California
- +37 more
Oct 5, 2020
Treatment Patterns and Clinical Response in Malignancy
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
-
Tucson, Arizona
- +44 more
Jun 11, 2019
Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,
Terminated
- Advanced Renal Cell Carcinoma
- +2 more
- Standard Treatment
- AGS-003
-
Scottsdale, Arizona
- +124 more
Jun 13, 2018
Metastatic Renal Cell Carcinoma Trial in Worldwide (Sunitinib, GM-CSF, Cyclophosphamide)
Completed
- Metastatic Renal Cell Carcinoma
- Sunitinib
- +3 more
-
Little Rock, Arkansas
- +105 more
Oct 4, 2017
Metastatic Renal Cell Carcinoma Trial in United States (Ramucirumab)
Completed
- Metastatic Renal Cell Carcinoma
- Ramucirumab
-
San Francisco, California
- +10 more
May 16, 2014
Metastatic Renal Cell Carcinoma Trial in Chicago (, Sorafenib)
Completed
- Metastatic Renal Cell Carcinoma
- placebo
- Sorafenib
-
Chicago, IllinoisThe University of Chicago
Mar 26, 2014
Metastatic Renal Cell Carcinoma Trial in Chicago (G250 peptide, IL-2)
Terminated
- Metastatic Renal Cell Carcinoma
- G250 peptide
- IL-2
-
Chicago, IllinoisThe University of Chicago
Sep 4, 2013
Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features Trial in United States (Doxorubicin,
Completed
- Metastatic Renal Cell Carcinoma
- Renal Cell Carcinoma With Sarcomatoid Features
- Doxorubicin
- +3 more
-
Los Angeles, California
- +91 more
Jan 4, 2013